Dr. Reddy's Laboratories Limited (RDY)
USD 14.55
(0.48%)
USD 14.55
(0.48%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | 334.02 INR | 23.04% |
| 2023 | 271.47 INR | 91.07% |
| 2022 | 142.08 INR | 36.69% |
| 2021 | 103.94 INR | -11.63% |
| 2020 | 117.62 INR | 3.83% |
| 2019 | 113.28 INR | 91.58% |
| 2018 | 59.13 INR | -18.15% |
| 2017 | 72.24 INR | -38.44% |
| 2016 | 117.34 INR | -9.89% |
| 2015 | 130.22 INR | 2.92% |
| 2014 | 126.52 INR | 28.03% |
| 2013 | 98.82 INR | 17.42% |
| 2012 | 84.16 INR | 28.92% |
| 2011 | 65.28 INR | 931.28% |
| 2010 | 6.33 INR | 120.62% |
| 2009 | -30.70 INR | -234.18% |
| 2008 | 22.88 INR | -60.86% |
| 2007 | 58.46 INR | 449.44% |
| 2006 | 10.64 INR | 671.01% |
| 2005 | 1.38 INR | -91.26% |
| 2004 | 15.79 INR | -31.5% |
| 2003 | 23.05 INR | -28.7% |
| 2002 | 32.33 INR | 452.65% |
| 2001 | 5.85 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | 78.49 INR | -5.22% |
| 2024 Q3 | 82.81 INR | -6.91% |
| 2024 Q1 | 84.21 INR | 45.72% |
| 2024 Q2 | 88.96 INR | 5.64% |
| 2024 FY | - INR | 23.48% |
| 2023 Q3 | 75.53 INR | 12.06% |
| 2023 Q4 | 57.79 INR | -23.49% |
| 2023 FY | - INR | 91.07% |
| 2023 Q2 | 67.40 INR | -5.81% |
| 2023 Q1 | 71.56 INR | 1257.87% |
| 2022 Q3 | 42.58 INR | -28.8% |
| 2022 Q4 | 5.27 INR | -87.62% |
| 2022 Q2 | 59.80 INR | 73.64% |
| 2022 Q1 | 34.44 INR | 3.18% |
| 2022 FY | - INR | 36.69% |
| 2021 Q1 | 34.94 INR | -24.21% |
| 2021 FY | - INR | -11.63% |
| 2021 Q2 | 45.96 INR | 31.54% |
| 2021 Q3 | 1.19 INR | -97.41% |
| 2021 Q4 | 33.38 INR | 2705.04% |
| 2020 Q1 | 39.98 INR | 52.6% |
| 2020 FY | - INR | 3.83% |
| 2020 Q4 | 46.10 INR | 234.13% |
| 2020 Q3 | -34.37 INR | -152.13% |
| 2020 Q2 | 65.93 INR | 64.91% |
| 2019 Q2 | 30.35 INR | 10.44% |
| 2019 Q1 | 27.48 INR | 50.91% |
| 2019 FY | - INR | 91.58% |
| 2019 Q3 | 29.25 INR | -3.62% |
| 2019 Q4 | 26.20 INR | -10.43% |
| 2018 Q2 | 17.18 INR | 381.23% |
| 2018 FY | - INR | -18.15% |
| 2018 Q4 | 18.21 INR | -9.67% |
| 2018 Q3 | 20.16 INR | 17.35% |
| 2018 Q1 | 3.57 INR | -81.06% |
| 2017 FY | - INR | -38.44% |
| 2017 Q3 | 28.38 INR | 59.44% |
| 2017 Q2 | 17.80 INR | 138.93% |
| 2017 Q1 | 7.45 INR | 70.48% |
| 2017 Q4 | 18.85 INR | -33.58% |
| 2016 Q2 | 42.32 INR | 15.28% |
| 2016 Q3 | 33.95 INR | -19.78% |
| 2016 FY | - INR | -9.89% |
| 2016 Q1 | 36.71 INR | 20.52% |
| 2016 Q4 | 4.37 INR | -87.13% |
| 2015 FY | - INR | 2.92% |
| 2015 Q2 | 33.70 INR | 4.21% |
| 2015 Q1 | 32.34 INR | 14.24% |
| 2015 Q4 | 30.46 INR | -9.67% |
| 2015 Q3 | 33.72 INR | 0.06% |
| 2014 FY | - INR | 28.03% |
| 2014 Q4 | 28.31 INR | -22.14% |
| 2014 Q3 | 36.36 INR | -10.42% |
| 2014 Q2 | 40.59 INR | 91.01% |
| 2014 Q1 | 21.25 INR | -36.79% |
| 2013 Q4 | 33.62 INR | 50.97% |
| 2013 Q1 | 19.81 INR | 27.89% |
| 2013 Q2 | 23.12 INR | 16.71% |
| 2013 FY | - INR | 17.42% |
| 2013 Q3 | 22.27 INR | -3.68% |
| 2012 Q1 | 15.52 INR | -21.5% |
| 2012 Q3 | 30.26 INR | 66.63% |
| 2012 FY | - INR | 28.92% |
| 2012 Q4 | 15.49 INR | -48.81% |
| 2012 Q2 | 18.16 INR | 17.01% |
| 2011 Q2 | 16.95 INR | 36.58% |
| 2011 FY | - INR | 931.28% |
| 2011 Q4 | 19.77 INR | 22.49% |
| 2011 Q3 | 16.14 INR | -4.78% |
| 2011 Q1 | 12.41 INR | 25.86% |
| 2010 Q1 | 14.51 INR | 124.94% |
| 2010 Q2 | 12.88 INR | -11.23% |
| 2010 Q3 | -30.91 INR | -339.98% |
| 2010 Q4 | 9.86 INR | 131.9% |
| 2010 FY | - INR | 120.62% |
| 2009 Q3 | 14.52 INR | 132.32% |
| 2009 FY | - INR | -234.18% |
| 2009 Q4 | -58.18 INR | -500.69% |
| 2009 Q2 | 6.25 INR | -5.3% |
| 2009 Q1 | 6.60 INR | 8.37% |
| 2008 Q3 | -5.04 INR | -137.92% |
| 2008 FY | - INR | -60.86% |
| 2008 Q1 | 9.53 INR | -53.35% |
| 2008 Q2 | 13.29 INR | 39.45% |
| 2008 Q4 | 6.09 INR | 220.83% |
| 2007 Q1 | 9.19 INR | 708.61% |
| 2007 Q3 | 11.82 INR | -34.95% |
| 2007 Q2 | 18.17 INR | 97.71% |
| 2007 FY | - INR | 449.44% |
| 2007 Q4 | 20.43 INR | 72.84% |
| 2006 Q2 | 5.84 INR | 157.27% |
| 2006 Q1 | 2.27 INR | 175.17% |
| 2006 FY | - INR | 671.01% |
| 2006 Q4 | -1.51 INR | -136.83% |
| 2006 Q3 | 4.10 INR | -29.79% |
| 2005 Q1 | 1.15 INR | 5.5% |
| 2005 Q4 | -3.02 INR | -1358.33% |
| 2005 Q3 | 0.24 INR | -92.9% |
| 2005 FY | - INR | -91.26% |
| 2005 Q2 | 3.38 INR | 193.91% |
| 2004 Q1 | 5.20 INR | 19.27% |
| 2004 FY | - INR | -31.5% |
| 2004 Q3 | 3.87 INR | -36.35% |
| 2004 Q4 | 1.09 INR | -71.83% |
| 2004 Q2 | 6.08 INR | 16.92% |
| 2003 Q2 | 6.23 INR | -21.34% |
| 2003 FY | - INR | -28.7% |
| 2003 Q1 | 7.92 INR | 15.96% |
| 2003 Q3 | 4.53 INR | -27.29% |
| 2003 Q4 | 4.36 INR | -3.75% |
| 2002 Q1 | 3.30 INR | 0.0% |
| 2002 Q2 | 13.86 INR | 320.0% |
| 2002 FY | - INR | 452.65% |
| 2002 Q4 | 6.83 INR | -20.21% |
| 2002 Q3 | 8.56 INR | -38.24% |
| 2001 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | -0.48 USD | 69687.5% |
| Bausch Health Companies Inc. | -1.62 USD | 20718.519% |
| Catalent, Inc. | -5.76 USD | 5898.958% |
| Emergent BioSolutions Inc. | -14.85 USD | 2349.293% |
| Elanco Animal Health Incorporated | -2.50 USD | 13460.8% |
| Perrigo Company plc | -0.09 USD | 355818.85% |
| Teva Pharmaceutical Industries Limited | -0.50 USD | 66904.0% |
| Zoetis Inc. | 5.08 USD | -6475.197% |